Menu Search
Equities

GeneDx Holdings Corp

WGS:NSQ

GeneDx Holdings Corp

Actions
Health CareHealth Care Providers
  • Price (USD)76.92
  • Today's Change3.53 / 4.81%
  • Shares traded492.30k
  • 1 Year change+5,956.69%
  • Beta2.0899
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year GeneDx Holdings Corp had revenues fall -13.69% from 234.69m to 202.57m, though the company grew net income from a loss of 548.98m to a smaller loss of 175.77m.
Gross margin59.48%
Net profit margin-31.25%
Operating margin-21.58%
Return on assets-20.21%
Return on equity-36.40%
Return on investment-24.54%
More ▼

Cash flow in USDView more

In 2023, cash reserves at GeneDx Holdings Corp fell by 37.64m. Cash Flow from Financing totalled 186.24m or 91.94% of revenues. In addition the company used 180.15m for operations while cash used for investing totalled 43.73m.
Cash flow per share-2.31
Price/Cash flow per share--
Book value per share7.45
Tangible book value per share1.55
More ▼

Balance sheet in USDView more

GeneDx Holdings Corp has a Debt to Total Capital ratio of 20.28%, a higher figure than the previous year's 2.38%.
Current ratio2.41
Quick ratio2.27
Total debt/total equity0.2544
Total debt/total capital0.2028
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.